Abstract:Human hemokinin-1 (h HK-1) and its truncated form h HK-1(4-11) are mammalian tachykinin peptides encoded by the recently identified TAC4 gene in human, and the biological functions of these peptides have not been well investigated. In the present study, an attempt has been made to investigate the effects and mechanisms of action of h HK-1 and h HK-1(4-11) in pain modulation at the supraspinal level in mice using the tail immersion test. Intracerebroventricular (i.c.v.) administration of h HK-1 (0.3, 1, 3 and 6 nmol/mouse) produced a dose- and time-related antinociceptive effect. This effect was significantly antagonized by the NK(1) receptor antagonist SR140333, but not by the NK(2) receptor antagonist SR48968, indicating that the analgesic effect induced by i.c.v. h HK-1 is mediated through the activation of NK(1) receptors. Interestingly, naloxone, beta-funaltrexamine and naloxonazine, but not naltrindole and nor-binaltorphimine, could also block the analgesic effect markedly, suggesting that this effect is related to descending mu opioidergic neurons (primary mu(1) subtype). Human HK-1(4-11) could also induce a dose- and time-dependent analgesic effect after i.c.v. administration, however, the potency of analgesia was less than h HK-1. Surprisingly, SR140333 could not modify this analgesic effect, suggesting that this effect is not mediated through the NK(1) receptors like h HK-1. SR48968 could modestly enhance the analgesic effect induced by h HK-1(4-11), indicating that a small amount of h HK-1(4-11) may bind to NK(2) receptors. Furthermore, none of the opioid receptor (OR) antagonists could markedly block the analgesia of h HK-1(4-11), suggesting that the analgesic effect is not mediated through the descending opioidergic neurons. Blocking of delta ORs significantly enhanced the analgesia, indicating that delta OR is a negatively modulatory factor in the analgesic effect of h HK-1(4-11). It is striking that bicuculline (a competitive antagonist at GABA(A) receptors) effectively blocked the analgesia induced by h HK-1(4-11), suggesting that this analgesic effect is mediated through the descending inhibitory GABAergic neurons. The novel mechanism involved in the analgesic effect of h HK-1(4-11), which is different from that of h HK-1, may pave the way for a new strategy for the investigation and control of pain.

The N-Terminal Domain of Human Hemokinin-1 Influences Functional Selectivity Property for Tachykinin Receptor Neurokinin-1

Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P

Differences in the Expression of Neurokinin Receptor in Neural and Bone Marrow Mesenchymal Cells: Implications for Neuronal Expansion from Bone Marrow Cells

Crosstalk Between Neurokinin Receptors is Relevant to Hematopoietic Regulation: Cloning and Characterization of Neurokinin-2 Promoter

Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors

Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists

Cloning of Human Preprotachykinin-I Promoter and the Role of Cyclic Adenosine 5 '-Monophosphate Response Elements in Its Expression by Il-1 and Stem Cell Factor

Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor.

Human Hemokinin-1 and Human Hemokinin-1(4–11), Mammalian Tachykinin Peptides, Suppress Proliferation and Induce Differentiation in HL-60 Cells

Hemokinin is a Hematopoietic-Specific Tachykinin That Regulates B Lymphopoiesis

Hemokinin-1 induces transcriptomic alterations in pain-related signaling processes in rat primary sensory neurons independent of NK1 tachykinin receptor activation

In Vivo Characterization of the Effects of Human Hemokinin-1 and Human Hemokinin-1(4-11), Mammalian Tachykinin Peptides, on the Modulation of Pain in Mice

Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats

Differential Modulations of KCNQ1 by Auxiliary Proteins KCNE1 and KCNE2

Hemokinin-1 activates the MAPK pathway and enhances B cell proliferation and antibody production.

Physical and Biological Significance of Peptide Sequences Mediating the Interaction Between High Molecular Weight Kininogen and Plasma Prekallikrein.

Effects and Mechanisms of Supraspinal Administration of Rat/mouse Hemokinin-1, a Mammalian Tachykinin Peptide, on Nociception in Mice

T-cell Developmental Blockage by Tachykinin Antagonists and the Role of Hemokinin 1 in T Lymphopoiesis

In Vitro Characterization of the Effects of Rat/mouse Hemokinin-1 on Mouse Colonic Contractile Activity: a Comparison with Substance P.

Human Hemokinin-1 Promotes Migration of Melanoma Cells and Increases MMP-2 and MT1-MMP Expression by Activating Tumor Cell NK1 Receptors

Identification Of Distinct Carboxyl-Terminal Domains Mediating Internalization And Down-Regulation Of The Hamster Alpha(1b) Adrenergic Receptor